STATIN-FIBRATE REPORT: Focus on Safety

Death due to cardiac causes was not different between groups. Overall mortality was higher in the clofibrate group vs. placebo (162 events in Group I vs. 127 events in Group II, p ................
................

In order to avoid copyright disputes, this page is only a partial summary.